Archit Organosys Limited carries a market capitalization of 1.20B, placing it among publicly traded companies globally. Its enterprise value stands at 969.88M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.20B |
| Enterprise Value | 969.88M |
Archit Organosys Limited currently has 20.52M shares outstanding.
| Shares Outstanding | 20.52M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Archit Organosys Limited trades at a trailing price-to-earnings ratio of 9.23. The price-to-sales ratio is 0.53, and the price-to-book ratio stands at 3.61.
| PE Ratio | 9.23 |
| PS Ratio | 0.53 |
| PB Ratio | 3.61 |
| P/TBV Ratio | 0.97 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Archit Organosys Limited trades at an EV/EBITDA multiple of 9.33 and an EV/FCF ratio of 58.01. The EV/Sales ratio of 0.69 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 9.33 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.69 |
| EV / EBITDA | 9.33 |
| EV / EBIT | 9.33 |
| EV / FCF | 58.01 |
Archit Organosys Limited maintains a current ratio of 1.41, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 32.98, indicating elevated leverage, while an interest coverage ratio of 4.54 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.41 |
| Quick Ratio | 0.05 |
| Debt / Equity | 32.98 |
| Debt / EBITDA | 2.42 |
| Interest Coverage | 4.54 |
Archit Organosys Limited posts a return on equity of 22.60 and a return on invested capital of 7.69.
| Return on Equity (ROE) | 22.60 |
| Return on Assets (ROA) | 6.44 |
| Return on Invested Capital (ROIC) | 7.69 |
| Return on Capital Employed (ROCE) | 15.68 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 26.99 |
Over the trailing twelve months, Archit Organosys Limited has paid 29.60M in income taxes, reflecting an effective tax rate of 26.93.
| Income Tax | 29.60M |
| Effective Tax Rate | 26.93 |
Archit Organosys Limited's stock has gained approximately 37.6% over the past 52 weeks. The 50-day moving average sits at 53.34, while the 200-day moving average is 45.29.
| Beta (5Y) | N/A |
| 52-Week Price Change | 37.6% |
| 50-Day Moving Average | 53.34 |
| 200-Day Moving Average | 45.29 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Archit Organosys Limited generated 1.41B in revenue and converted that into 80.32M in net income, yielding earnings per share of 3.92. EBITDA reached 103.96M, while operating income came in at 103.96M.
| Revenue | 1.41B |
| Gross Profit | 430.90M |
| Operating Income | 103.96M |
| Pretax Income | 109.93M |
| Net Income | 80.32M |
| EBITDA | 103.96M |
| EBIT | 103.96M |
| Earnings Per Share (EPS) | 3.92 |
Archit Organosys Limited holds 22.57M in cash and equivalents against 251.40M in total debt, resulting in a net debt position of 232.90M. Total book value stands at 205.21M, with working capital of 177.04M providing operational flexibility.
| Cash & Cash Equivalents | 22.57M |
| Total Debt | 251.40M |
| Net Debt | 232.90M |
| Equity (Book Value) | 205.21M |
| Book Value Per Share | 10.01 |
| Working Capital | 177.04M |
Archit Organosys Limited operates with a gross margin of 30.57, reflecting its pricing power and cost economics. The operating margin of 7.38 and net profit margin of 5.70 provide insight into operational efficiency.
| Gross Margin | 30.57 |
| Operating Margin | 7.38 |
| Pretax Margin | 7.80 |
| Profit Margin | 5.70 |
| EBITDA Margin | 7.38 |
Archit Organosys Limited's most recent stock split took place on February 9, 2017 with a 125:237 split ratio.
| Last Split Date | 2/9/2017 |
| Split Ratio | 125:237 |
Archit Organosys Limited posts an Altman Z-Score of 2.43, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.43 |